Acute effects of nasal salmon calcitonin on calcium and bone metabolism
✍ Scribed by Gorm Thamsborg; Søren Glud Skousgaard; Henrik Daugaard; Søren Schifter; Gina Kollerup; Ole Helmer Sørensen
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 502 KB
- Volume
- 53
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Twenty-four women (mean age +/- SD 49 +/- 13 years) with classical or definite rheumatoid arthritis (disease duration 15 +/- 8 years) were treated with synthetic salmon calcitonin (SCT) nasal spray 200 IU three times a week for 3 months. Bone biopsies from the iliac crest were taken before and after
Hypercalcemia of malignancy is a commonly encountered serious clinical problem that often requires aggressive therapy. In order to combine the rapid hypocalcemic effects of calcitonin with the more delayed effect of a bisphosphonate, we administered etidronate, 7.5 mg/kg/day intravenously and salmon